{"id":243,"date":"2026-09-10T09:00:00","date_gmt":"2026-09-10T09:00:00","guid":{"rendered":"https:\/\/cntumour.com\/wp-content\/uploads\/2026\/10\/Acute-Lymphoblastic-Leukemia-ALL.jpg"},"modified":"2026-10-29T15:53:20","modified_gmt":"2026-10-29T15:53:20","slug":"acute-lymphoblastic-leukemia-all","status":"publish","type":"cancer_type","link":"https:\/\/cntumour.com\/zh-hk\/cancer\/acute-lymphoblastic-leukemia-all\/","title":{"rendered":"\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09"},"content":{"rendered":"<div class=\"ac-blog-article\">\n<p class=\"ac-blog-lead\"><strong>\u4e86\u89e3\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u5c0d\u65bc\u5be6\u73fe\u65e9\u671f\u767c\u73fe\u548c\u6709\u6548\u6cbb\u7642\u7d50\u679c\u81f3\u95dc\u91cd\u8981\u3002ALL \u662f\u4e00\u7a2e\u60e1\u6027\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u662f\u672a\u6210\u719f\u6dcb\u5df4\u7d30\u80de\uff08\u6dcb\u5df4\u6bcd\u7d30\u80de\uff09\u5feb\u901f\u4e14\u4e0d\u53d7\u63a7\u5236\u5730\u589e\u6b96\u3002\u9019\u4e9b\u764c\u7d30\u80de\u5728\u9aa8\u9ad3\u4e2d\u7a4d\u805a\uff0c\u7834\u58de\u6b63\u5e38\u7684\u9020\u8840\u4f5c\u7528\uff08\u8840\u7403\u751f\u6210\uff09\uff0c\u6700\u7d42\u53d6\u4ee3\u5065\u5eb7\u7684\u9020\u8840\u7d30\u80de\u3002\u56e0\u6b64\uff0c\u5065\u5eb7\u8840\u7403\u56b4\u91cd\u77ed\u7f3a\uff0c\u5c0e\u81f4\u8ca7\u8840\u3001\u611f\u67d3\u589e\u52a0\u548c\u51fa\u8840\u50be\u5411\u3002<\/strong><\/p>\n<nav class=\"ac-blog-toc\" aria-label=\"\u672c\u6587\u5c0e\u89bd\">\n<p><strong>\u672c\u6587\u5c0e\u89bd<\/strong><\/p>\n<ul>\n<li><a href=\"#what-is-acute-lymphoblastic-leukemia-all\">\u4ec0\u9ebc\u662f\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09\uff1f<\/a><\/li>\n<li><a href=\"#causes-and-risk-factors-of-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u75c5\u56e0\u548c\u98a8\u96aa\u56e0\u7d20<\/a><\/li>\n<li><a href=\"#symptoms-of-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u75c7\u72c0<\/a><\/li>\n<li><a href=\"#stages-of-acute-lymphoblastic-leukemia-all-and-survival-rates\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u968e\u6bb5\u548c\u5b58\u6d3b\u7387<\/a><\/li>\n<li><a href=\"#limitations-of-traditional-therapies-for-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u50b3\u7d71\u7642\u6cd5\u7684\u5c40\u9650\u6027<\/a><\/li>\n<\/ul>\n<\/nav>\n<h2 id=\"what-is-acute-lymphoblastic-leukemia-all\">\u4ec0\u9ebc\u662f\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09\uff1f<\/h2>\n<p>\u5728 ALL \u4e2d\uff0c\u764c\u7d30\u80de\u8868\u73fe\u51fa\u986f\u8457\u7684\u4ee3\u8b1d\u91cd\u7de8\u7a0b\uff0c\u7279\u5225\u662f Warburg \u6548\u61c9\u3002\u9019\u7a2e\u6a19\u8a8c\u6027\u7684\u4ee3\u8b1d\u8f49\u8b8a\u4f7f\u5f97\u764c\u7d30\u80de\u767d\u8840\u75c5\u7d30\u80de\u80fd\u5920\u4ee5\u6bd4\u975e\u60e1\u6027\u7d30\u80de\u9ad8\u7d04 200 \u500d\u7684\u901f\u7387\u9032\u884c\u8461\u8404\u7cd6\u7121\u6c27\u4ee3\u8b1d\u3002\u9019\u5c0e\u81f4\u7cd6\u89e3\u7387\u589e\u52a0\uff0c\u63d0\u4f9b\u7dad\u6301\u7d30\u80de\u904e\u5ea6\u589e\u6b96\u548c\u751f\u9577\u7684\u5fc5\u9700\u80fd\u91cf\u548c\u751f\u7269\u5408\u6210\u524d\u9a45\u7269\u3002<\/p>\n<h3 id=\"incidence-and-engagement-in-hong-kong-and-asia\">\u9999\u6e2f\u548c\u4e9e\u6d32\u7684\u767c\u751f\u7387\u548c\u53c3\u8207\u5ea6<\/h3>\n<p>\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u4e3b\u8981\u4ee3\u8868\u6700\u5e38\u898b\u7684\u5152\u79d1\u60e1\u6027\u816b\u7624\uff0c\u7d04\u4f54\u5168\u7403\u5152\u7ae5\u764c\u75c7\u7684 25%\u3002\u5728\u9999\u6e2f\uff0c\u6bcf\u5e74\u8a3a\u65b7\u51fa\u7d04 100-120 \u4f8b ALL \u75c5\u4f8b\u3002\u767c\u751f\u7387\u5f98\u5f8a\u5728\u6bcf 10 \u842c\u4eba 3.4 \u4f8b\u5de6\u53f3\uff0c\u4e3b\u8981\u5f71\u97ff 15 \u6b72\u4ee5\u4e0b\u5152\u7ae5\u3002\u7136\u800c\uff0c\u6210\u5e74\u4eba\u4ecd\u7136\u6613\u611f\uff0c50 \u6b72\u5f8c\u51fa\u73fe\u7b2c\u4e8c\u500b\u767c\u75c5\u9ad8\u5cf0\u3002<\/p>\n<ul>\n<li>\u5152\u7ae5\u60a3\u8005\uff080-14 \u6b72\uff09\u7d04\u4f54 ALL \u75c5\u4f8b\u7e3d\u6578\u7684 80%\u3002<\/li>\n<li>\u5b58\u6d3b\u7387\u6839\u64da\u5e74\u9f61\u3001\u907a\u50b3\u4e9e\u578b\u548c\u6cbb\u7642\u65b9\u5f0f\u800c\u6709\u5f88\u5927\u5dee\u7570\u3002<\/li>\n<li>\u5148\u9032\u7684\u4ee3\u8b1d\u7642\u6cd5\u5275\u65b0\u5927\u5927\u63d0\u9ad8\u4e86\u9999\u6e2f\u548c\u6574\u500b\u4e9e\u6d32\u7684\u751f\u5b58\u7387\u3002<\/li>\n<\/ul>\n<p>\u5728\u60c5\u7dd2\u548c\u8eab\u9ad4\u4e0a\uff0cALL \u8a3a\u65b7\u5e36\u4f86\u4e86\u5de8\u5927\u7684\u6311\u6230\uff0c\u5c0e\u81f4\u75b2\u52de\u3001\u8eab\u9ad4\u4e0d\u9069\u548c\u5de8\u5927\u7684\u5fc3\u7406\u58d3\u529b\u3002\u5bb6\u5ead\u548c\u7167\u8b77\u4eba\u54e1\u7684\u65e5\u5e38\u751f\u6d3b\u88ab\u6253\u4e82\u3001\u7d93\u6fdf\u7dca\u5f35\u548c\u60c5\u7dd2\u56f0\u64fe\u3002\u56e0\u6b64\uff0c\u53ca\u6642\u6709\u6548\u7684\u5e72\u9810\u63aa\u65bd\uff0c\u5982\u9769\u547d\u6027\u7684\u9999\u6e2f\u4ee3\u8b1d\u7642\u6cd5\uff0c\u5c0d\u65bc\u6539\u5584\u7d50\u679c\u548c\u751f\u6d3b\u8cea\u7d20\u81f3\u95dc\u91cd\u8981\u3002<\/p>\n<h3 id=\"advances-in-acute-lymphoblastic-leukemia-all-management\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u6cbb\u7642\u7684\u9032\u5c55<\/h3>\n<p>\u5c08\u6ce8\u65bc\u91dd\u5c0d\u74e6\u723e\u5821\u6548\u61c9\u7522\u751f\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\u7684\u5275\u65b0\u7642\u6cd5\u63d0\u4f9b\u4e86\u6709\u5e0c\u671b\u7684\u65b0\u6cbb\u7642\u9078\u64c7\u3002\u672c\u8cea\u4e0a\u4ee3\u8b1d\u7684\u6cbb\u7642\u7b56\u7565\u6703\u986f\u8457\u640d\u5bb3\u764c\u7d30\u80de\u589e\u6b96\uff0c\u540c\u6642\u4fdd\u7559\u5065\u5eb7\u7d30\u80de\uff0c\u5f9e\u800c\u6700\u5927\u9650\u5ea6\u5730\u6e1b\u5c11\u50b3\u7d71\u5316\u7642\u7684\u526f\u4f5c\u7528\u3002\u5982\u9700\u66f4\u591a\u4e86\u89e3\uff0c\u8acb\u700f\u89bd\u6211\u5011\u7684\u9801\u9762 <a href=\"\/zh-hk\/treatment-cancer\/\">\u4ee3\u8b1d\u816b\u7624\u5b78<\/a>.<\/p>\n<p>\u6211\u5011\u5728 AllCancer \u7684\u81e8\u5e8a\u7d93\u9a57\u5df2\u6210\u529f\u6cbb\u7642\u8d85\u904e 12,000 \u4f8b\u764c\u75c7\u75c5\u4f8b\uff0c\u5176\u4e2d\u5305\u62ec\u8a31\u591a ALL \u75c5\u4f8b\uff0c\u9019\u8b49\u660e\u4e86\u500b\u9ad4\u5316\u4ee3\u8b1d\u6cbb\u7642\u7684\u986f\u8457\u76ca\u8655\u3002\u60a3\u8005\u7684\u611f\u8a00\uff0c\u4f8b\u5982 John \u900f\u904e 4D \u4ee3\u8b1d\u7642\u6cd5\u7372\u5f97\u7684\u7de9\u89e3\uff0c\u5f37\u5316\u4e86\u5c07\u5275\u65b0\u4ee3\u8b1d\u816b\u7624\u5b78\u7d0d\u5165\u6240\u6709\u6cbb\u7642\u65b9\u6848\u7684\u7406\u7531\u3002\u5728\u6211\u5011\u5c08\u9580\u7684\u7db2\u7ad9\u4e0a\u767c\u73fe\u66f4\u591a\u6709\u5f71\u97ff\u529b\u7684\u60a3\u8005\u6545\u4e8b <a href=\"\/zh-hk\/about\/\">\u60a3\u8005\u6545\u4e8b<\/a> \u90e8\u5206\u3002<\/p>\n<h2 id=\"causes-and-risk-factors-of-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u75c5\u56e0\u548c\u98a8\u96aa\u56e0\u7d20<\/h2>\n<p>\u78ba\u5b9a\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u6e96\u78ba\u75c5\u56e0\u548c\u98a8\u96aa\u56e0\u7d20\u5c0d\u65bc\u6709\u91dd\u5c0d\u6027\u7684\u9810\u9632\u548c\u65e9\u671f\u8a3a\u65b7\u7b56\u7565\u4ecd\u7136\u81f3\u95dc\u91cd\u8981\u3002\u7814\u7a76\u4eba\u54e1\u8a8d\u8b58\u5230\u907a\u50b3\u50be\u5411\u3001\u74b0\u5883\u5f71\u97ff\u548c\u751f\u6d3b\u65b9\u5f0f\u56e0\u7d20\u4e4b\u9593\u5b58\u5728\u591a\u65b9\u9762\u7684\u76f8\u4e92\u4f5c\u7528\uff0c\u6bcf\u500b\u56e0\u7d20\u90fd\u53ef\u80fd\u5c0e\u81f4\u75be\u75c5\u7684\u767c\u751f\u548c\u9032\u5c55\u3002<\/p>\n<h3 id=\"genetic-factors-influencing-all-development\">\u5f71\u97ff\u6240\u6709\u767c\u80b2\u7684\u907a\u50b3\u56e0\u7d20<\/h3>\n<p>\u67d0\u4e9b\u907a\u50b3\u56e0\u7d20\u986f\u8457\u589e\u52a0 ALL \u7684\u6613\u611f\u6027\u3002\u67d3\u8272\u9ad4\u7570\u5e38\uff0c\u4f8b\u5982\u8d85\u4e8c\u500d\u9ad4\u3001\u4e9e\u4e8c\u500d\u9ad4\u3001\u8cbb\u57ce\u67d3\u8272\u9ad4\uff08BCR-ABL1 \u6613\u4f4d\uff09\u4ee5\u53ca\u6d89\u53ca MLL \u57fa\u56e0\u7684\u91cd\u6392\uff0c\u5f62\u6210\u4e0d\u540c\u7684 ALL \u4e9e\u578b\uff1a<\/p>\n<ul>\n<li>\u8cbb\u57ce\u967d\u6027 ALL \u7d04\u4f54\u6210\u4eba ALL \u75c5\u4f8b\u7684 20-30%\uff0c\u56e0\u6b64\u9700\u8981\u5728\u5e38\u898f\u6cbb\u7642\u7684\u540c\u6642\u9032\u884c\u6a19\u9776\u5206\u5b50\u6cbb\u7642\u3002<\/li>\n<li>\u7279\u5b9a\u7684\u907a\u50b3\u7d9c\u5408\u75c7\uff08\u5510\u6c0f\u75c7\u3001\u5e03\u9b6f\u59c6\u7d9c\u5408\u75c7\u3001\u7bc4\u53ef\u5c3c\u8ca7\u8840\uff09\u6703\u5927\u5927\u589e\u52a0 ALL \u98a8\u96aa\uff0c\u51f8\u986f\u4e86\u65e9\u671f\u907a\u50b3\u8aee\u8a62\u548c\u5b9a\u671f\u7be9\u6aa2\u7684\u5fc5\u8981\u6027\u3002<\/li>\n<\/ul>\n<h3 id=\"environmental-and-lifestyle-risk-factors-for-all\">\u6240\u6709\u4eba\u7684\u74b0\u5883\u548c\u751f\u6d3b\u65b9\u5f0f\u98a8\u96aa\u56e0\u7d20<\/h3>\n<p>\u74b0\u5883\u56e0\u7d20\u986f\u8457\u5f71\u97ff ALL \u7684\u767c\u75c5\uff0c\u5168\u7403\u516c\u8a8d\u74b0\u5883\u56e0\u7d20\u6703\u589e\u52a0\u98a8\u96aa\uff1a<\/p>\n<ul>\n<li>\u96fb\u96e2\u8f3b\u5c04\u66b4\u9732\u986f\u8457\u589e\u52a0\u6240\u6709\u98a8\u96aa\u2014\u9019\u9805\u89c0\u5bdf\u5728\u539f\u5b50\u5f48\u767c\u751f\u548c\u6cbb\u7642\u8f3b\u5c04\u61c9\u7528\u5f8c\u5f97\u5230\u52a0\u5f37\u3002<\/li>\n<li>\u82ef\u662f\u4e00\u7a2e\u5ee3\u6cdb\u7528\u65bc\u5de5\u696d\u751f\u7522\u7684\u5df2\u77e5\u81f4\u767d\u8840\u75c5\u5316\u5b78\u7269\u8cea\uff0c\u63a5\u89f8\u82ef\u6703\u589e\u52a0 ALL \u7684\u767c\u751f\u7387\u3002<\/li>\n<li>\u9577\u671f\u548c\u9ad8\u6fc3\u5ea6\u8fb2\u85e5\u66b4\u9732\u59cb\u7d42\u8207\u767d\u8840\u75c5\u98a8\u96aa\u589e\u52a0\u6709\u95dc\u3002<\/li>\n<\/ul>\n<p>\u5728\u4e9e\u6d32\uff0c\u5ee3\u6cdb\u7684\u57ce\u5e02\u5de5\u696d\u5316\u589e\u52a0\u4e86\u6f5b\u5728\u7684\u66b4\u9732\uff0c\u7a81\u986f\u4e86\u9999\u6e2f\u74b0\u4fdd\u6a5f\u69cb\u6700\u8fd1\u70ba\u76e3\u6e2c\u548c\u76e1\u91cf\u6e1b\u5c11\u82ef\u548c\u8fb2\u85e5\u76f8\u95dc\u98a8\u96aa\u800c\u63a1\u53d6\u7684\u7a4d\u6975\u52aa\u529b\u3002<\/p>\n<h3 id=\"metabolic-vulnerabilities-in-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u4ee3\u8b1d\u8106\u5f31\u6027<\/h3>\n<p>\u6240\u6709\u7d30\u80de\u90fd\u8868\u73fe\u51fa\u986f\u8457\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\uff0c\u7279\u5225\u662f\u8461\u8404\u7cd6\u548c\u9ea9\u91af\u80fa\u9178\u4f9d\u8cf4\u6027\u3002\u8461\u8404\u7cd6\u4f9d\u8cf4\u6027\uff08\u74e6\u4f2f\u683c\u6548\u61c9\uff09\u5df2\u5f97\u5230\u5145\u5206\u8b49\u660e\uff0c\u4f46\u6b64\u5916\uff0c\u5927\u7d04 50% \u7684\u764c\u7d30\u80de\u8868\u73fe\u51fa\u5c0d\u8c37\u6c28\u9170\u80fa\u7684\u6838\u82f7\u9178\u751f\u7269\u5408\u6210\u548c\u80fd\u91cf\u4ee3\u8b1d\u7684\u56b4\u91cd\u4f9d\u8cf4\u3002<\/p>\n<p>\u9019\u4e9b\u6f0f\u6d1e\u70ba\u6709\u91dd\u5c0d\u6027\u7684\u6cbb\u7642\u4ecb\u5165\u958b\u95e2\u4e86\u9014\u5f91\uff1a<\/p>\n<ul>\n<li>\u7cd6\u89e3\u9014\u5f91\u7684\u6291\u5236\uff08\u4f8b\u5982\u900f\u904e\u8461\u8404\u7cd6\u4ee3\u8b1d\u6291\u5236\u5291\uff09\u5728\u6e1b\u7de9 ALL \u9032\u5c55\u65b9\u9762\u986f\u793a\u51fa\u5de8\u5927\u7684\u524d\u666f\u3002<\/li>\n<li>\u91dd\u5c0d\u9ea9\u91af\u80fa\u9178\u4ee3\u8b1d\u7684\u7b56\u7565\u53ef\u6700\u5927\u9650\u5ea6\u5730\u6e1b\u5c11\u6838\u82f7\u9178\u5408\u6210\u548c ATP \u7522\u751f\uff0c\u6709\u6548\u5730\u4f7f\u767d\u8840\u75c5\u7d30\u80de\u7fa4\u6328\u9913\uff0c\u540c\u6642\u907f\u514d\u5c0d\u6b63\u5e38\u7d30\u80de\u7522\u751f\u986f\u8457\u6bd2\u6027\u3002<\/li>\n<\/ul>\n<p>\u7d9c\u5408\u4ee3\u8b1d\u6a19\u9776\u6cbb\u7642\u662f\u4e00\u500b\u6d3b\u8e8d\u7684\u7814\u7a76\u9818\u57df\uff0c\u53cd\u6620\u4e86\u683c\u96f7\u683c\u00b7\u585e\u9580\u624e\u6559\u6388\u7b49\u8afe\u8c9d\u723e\u734e\u5f97\u4e3b\u5c0d\u7f3a\u6c27\u8a98\u5c0e\u7684\u4ee3\u8b1d\u91cd\u7de8\u7a0b\u7684\u958b\u5275\u6027\u7814\u7a76\u3002<\/p>\n<h3 id=\"early-detection-and-preventive-measures\">\u65e9\u671f\u767c\u73fe\u8207\u9810\u9632\u63aa\u65bd<\/h3>\n<p>\u5be6\u65bd\u5b9a\u671f\u7be9\u6aa2\u548c\u57fa\u56e0\u6aa2\u6e2c\uff0c\u7279\u5225\u662f\u5728\u9ad8\u98a8\u96aa\u65cf\u7fa4\u4e2d\uff0c\u53ef\u4ee5\u5927\u5e45\u63d0\u9ad8\u65e9\u671f ALL \u7684\u6aa2\u6e2c\u7387\uff0c\u6539\u5584\u81e8\u5e8a\u7d50\u679c\u3002\u81f3\u95dc\u91cd\u8981\u7684\u662f\uff0c\u4e9e\u6d32\u548c\u9999\u6e2f\u7684\u885b\u751f\u7d44\u7e54\u5021\u8b70\uff1a<\/p>\n<ul>\n<li>\u5b9a\u671f\u5065\u5eb7\u6aa2\u67e5\uff0c\u767c\u73fe\u8eab\u9ad4\u75c7\u72c0\uff08\u75b2\u52de\u3001\u4e0d\u660e\u539f\u56e0\u51fa\u8840\u3001\u6301\u7e8c\u611f\u67d3\uff09\u6642\u7acb\u5373\u5c31\u8a3a\u3002<\/li>\n<li>\u6e1b\u5c11\u74b0\u5883\u98a8\u96aa\u7684\u610f\u8b58\u8a08\u756b\uff0d\u9650\u5236\u82ef\u548c\u8fb2\u85e5\u63a5\u89f8\uff0c\u78ba\u4fdd\u5de5\u4f5c\u5834\u6240\u5b89\u5168\uff0c\u4e26\u53ca\u6642\u901a\u5831\u5371\u96aa\u5316\u5b78\u54c1\u4e8b\u6545\u3002<\/li>\n<\/ul>\n<p>AllCancer \u5718\u968a\u8207\u674e\u570b\u83ef\u535a\u58eb\u548c\u5289\u570b\u9f8d\u6559\u6388\u7b49\u5091\u51fa\u9818\u5c0e\u8005\u5bc6\u5207\u5408\u4f5c\uff0c\u5229\u7528\u4f86\u81ea FDA \u7684\u5354\u4f5c\u898b\u89e3\u548c\u5c08\u696d\u77e5\u8b58\u3001EMA \u8a8d\u8b49\u7684\u65b9\u6848\u4ee5\u53ca\u8de8\u8d8a\u7f8e\u570b\u3001\u6b50\u76df\u3001\u65e5\u672c\u548c\u4e2d\u570b\u7684\u5c08\u5229\uff0c\u9ad4\u73fe\u4e86\u53ef\u4fe1\u5ea6\u548c\u6b0a\u5a01\u7684\u81e8\u5e8a\u5be6\u8e10\u3002<\/p>\n<p>\u63a2\u7d22 4D \u4ee3\u8b1d\u7642\u6cd5\u5982\u4f55\u5275\u65b0\u5730\u6539\u8b8a\u6240\u6709\u7ba1\u7406 - \u8acb\u7acb\u5373\u806f\u7e6b\u6211\u5011\u3002\u6211\u5011\u5c08\u9580\u7684\u300c\u5148\u6cbb\u6108\uff0c\u5f8c\u4ed8\u6b3e\u300d\u653f\u7b56\u548c\u5bcc\u6709\u540c\u60c5\u5fc3\u7684\u8b77\u7406\u627f\u8afe\u70ba\u9999\u6e2f\u53ca\u5176\u4ed6\u5730\u5340\u7684\u6240\u6709\u60a3\u8005\u63d0\u4f9b\u5148\u9032\u7684\u816b\u7624\u5b78\u89e3\u6c7a\u65b9\u6848\u3002<\/p>\n<h2 id=\"symptoms-of-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u75c7\u72c0<\/h2>\n<p>\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u65e9\u671f\u767c\u73fe\u53ef\u986f\u8457\u6539\u5584\u9810\u5f8c\u548c\u6210\u529f\u6cbb\u7642\u7684\u53ef\u80fd\u6027\u3002\u53ca\u65e9\u8b58\u5225\u75c7\u72c0\u81f3\u95dc\u91cd\u8981\uff0c\u7279\u5225\u662f\u56e0\u70ba\u4e00\u4e9b\u6307\u6a19\u5f88\u5fae\u5999\u4e26\u4e14\u53ef\u4ee5\u6a21\u64ec\u5e38\u898b\u60c5\u6cc1\u3002\u4ee5\u4e0b\u662f\u660e\u78ba\u5206\u985e\u7684\u5e38\u898b\u75c7\u72c0\uff0c\u4ee5\u5e6b\u52a9\u63d0\u9ad8\u610f\u8b58\uff1a<\/p>\n<h3 id=\"general-symptoms\">\u4e00\u822c\u75c7\u72c0<\/h3>\n<ul>\n<li>\u7531\u65bc\u9aa8\u9ad3\u4e2d\u7d05\u8840\u7403\u751f\u6210\u6e1b\u5c11\u800c\u5c0e\u81f4\u8ca7\u8840\uff0c\u5c0e\u81f4\u75b2\u52de\u548c\u865b\u5f31\u3002<\/li>\n<li>\u7531\u65bc\u8840\u5c0f\u677f\u8a08\u6578\u6e1b\u5c11\uff08\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\uff09\u800c\u5c0e\u81f4\u904e\u5ea6\u7600\u50b7\u6216\u7570\u5e38\u51fa\u8840\u3002<\/li>\n<li>\u7531\u65bc\u767d\u8840\u7403\u751f\u6210\u7121\u6548\u800c\u5c0e\u81f4\u514d\u75ab\u529b\u53d7\u640d\uff0c\u5c0e\u81f4\u983b\u7e41\u611f\u67d3\u3002<\/li>\n<li>\u5373\u4f7f\u5728\u6297\u751f\u7d20\u6cbb\u7642\u5f8c\u4ecd\u6301\u7e8c\u767c\u71d2\u6216\u611f\u67d3\u3002<\/li>\n<li>\u98df\u617e\u4e0d\u632f\u548c\u9ad4\u91cd\u610f\u5916\u986f\u8457\u6e1b\u8f15\u3002<\/li>\n<li>\u7531\u65bc\u767d\u8840\u75c5\u7d30\u80de\u5728\u9aa8\u9ad3\u548c\u9aa8\u819c\u4e2d\u7a4d\u805a\u800c\u5f15\u8d77\u7684\u9aa8\u9abc\u548c\u95dc\u7bc0\u75bc\u75db\u6216\u58d3\u75db\u3002<\/li>\n<li>\u6dcb\u5df4\u7d50\u816b\u5927\u5728\u9838\u90e8\u3001\u814b\u4e0b\u6216\u8179\u80a1\u6e9d\u5340\u57df\u5c24\u5176\u660e\u986f\u3002<\/li>\n<li>\u7531\u65bc\u767d\u8840\u75c5\u6d78\u6f64\u5c0e\u81f4\u813e\u81df\u6216\u809d\u81df\u816b\u5927\uff08\u809d\u813e\u816b\u5927\uff09\uff0c\u5c0e\u81f4\u8179\u90e8\u816b\u8139\u6216\u4e0d\u9069\u3002<\/li>\n<li>\u76dc\u6c57\u6703\u5c0e\u81f4\u56b4\u91cd\u4e0d\u9069\u548c\u7761\u7720\u969c\u7919\u3002<\/li>\n<li>\u7531\u65bc\u767d\u8840\u75c5\u7d30\u80de\u6d78\u6f64\u8166\u810a\u9ad3\u6db2\u548c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff08CNS\uff09\u800c\u5c0e\u81f4\u982d\u75db\u6216\u982d\u6688\u3002<\/li>\n<\/ul>\n<h3 id=\"symptoms-variations-by-disease-progression\">\u75c7\u72c0\u96a8\u75be\u75c5\u9032\u5c55\u800c\u8b8a\u5316<\/h3>\n<p>ALL \u901a\u5e38\u9032\u5c55\u8fc5\u901f\uff0c\u96a8\u8457\u75be\u75c5\u7684\u9032\u5c55\uff0c\u75c7\u72c0\u53ef\u80fd\u6703\u986f\u8457\u8b8a\u5316\u3002<\/p>\n<h4>\u65e9\u671f\u75c7\u72c0<\/h4>\n<ul>\n<li>\u6301\u7e8c\u75b2\u52de\uff0c\u904b\u52d5\u8010\u53d7\u6027\u5fae\u5999\u4e0b\u964d\u3002<\/li>\n<li>\u5c0d\u611f\u5192\u6216\u6d41\u611f\u985e\u75be\u75c5\u7b49\u611f\u67d3\u7684\u6613\u611f\u6027\u8f03\u5e73\u5e38\u4f4e\uff0c\u4e14\u6301\u7e8c\u6642\u9593\u6bd4\u5e73\u5e38\u9577\u3002<\/li>\n<li>\u5076\u723e\u6709\u7600\u50b7\u6216\u8f15\u5fae\u3001\u4e0d\u660e\u539f\u56e0\u7684\u51fa\u8840\uff08\u9f3b\u5b50\u6216\u7259\u9f66\uff09\u3002<\/li>\n<\/ul>\n<h4>\u4e2d\u671f\u75c7\u72c0<\/h4>\n<ul>\n<li>\u7531\u65bc\u4e2d\u5ea6\u8ca7\u8840\u800c\u5c0e\u81f4\u660e\u986f\u4e14\u6301\u7e8c\u7684\u84bc\u767d\u3002<\/li>\n<li>\u611f\u67d3\u589e\u52a0\uff0c\u5305\u62ec\u80ba\u708e\u3001\u9f3b\u7ac7\u708e\u6216\u6ccc\u5c3f\u9053\u611f\u67d3\u3002<\/li>\n<li>\u95dc\u7bc0\u548c\u9aa8\u9abc\u75bc\u75db\u8b8a\u5f97\u8d8a\u4f86\u8d8a\u983b\u7e41\u548c\u660e\u986f\u3002<\/li>\n<li>\u4e0d\u660e\u539f\u56e0\u7684\u9ad4\u91cd\u6e1b\u8f15\u8b8a\u5f97\u986f\u8457\u4e14\u66f4\u52a0\u660e\u986f\u3002<\/li>\n<\/ul>\n<h4>\u665a\u671f\u75c7\u72c0<\/h4>\n<ul>\n<li>\u7531\u65bc\u6dcb\u5df4\u7d50\u816b\u5927\u58d3\u8feb\u6c23\u9053\u6216\u80f8\u90e8\u611f\u67d3\u5f15\u8d77\u56b4\u91cd\u547c\u5438\u7a98\u8feb\u3002<\/li>\n<li>\u795e\u7d93\u7cfb\u7d71\u75c7\u72c0\uff0c\u5305\u62ec\u7672\u7647\u767c\u4f5c\u3001\u8996\u529b\u6a21\u7cca\u3001\u56b4\u91cd\u982d\u75db\u6216\u5176\u4ed6\u767d\u8840\u75c5\u6d78\u6f64\u5c0e\u81f4\u7684\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u8868\u73fe\u3002<\/li>\n<li>\u56b4\u91cd\u8ca7\u8840\u548c\u56b4\u91cd\u75b2\u52de\u56b4\u91cd\u5f71\u97ff\u65e5\u5e38\u751f\u6d3b\u3002<\/li>\n<li>\u51fa\u8840\u4e8b\u4ef6\u8b8a\u5f97\u56b4\u91cd\uff0c\u53ef\u80fd\u5371\u53ca\u751f\u547d\uff0c\u5305\u62ec\u5668\u5b98\u81ea\u767c\u6027\u51fa\u8840\u6216\u56b4\u91cd\u6d41\u9f3b\u8840\u3002<\/li>\n<\/ul>\n<p>\u8a8d\u8b58\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u65e9\u671f\u75c7\u72c0\u81f3\u95dc\u91cd\u8981\u3002\u65e9\u671f\u8a3a\u65b7\u5927\u5927\u63d0\u9ad8\u6cbb\u7642\u6210\u529f\u7387\u548c\u9810\u5f8c\u3002\u5982\u679c\u4efb\u4f55\u9019\u4e9b\u75c7\u72c0\u6301\u7e8c\u5b58\u5728\u6216\u5f15\u8d77\u95dc\u6ce8\uff0c\u5efa\u8b70\u7acb\u5373\u5c31\u91ab\uff0c\u4ee5\u78ba\u4fdd\u53ca\u6642\u548c\u9069\u7576\u7684\u5e72\u9810\u3002\u6709\u95dc\u8a3a\u65b7\u7684\u8a73\u7d30\u8cc7\u8a0a\uff0c\u8acb\u63a2\u7d22\u6211\u5011\u7684\u5c08\u7528 <a href=\"\/zh-hk\/cancer\/\">\u8a3a\u65b7\u9801\u9762<\/a>.<\/p>\n<h2 id=\"stages-of-acute-lymphoblastic-leukemia-all-and-survival-rates\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u968e\u6bb5\u548c\u5b58\u6d3b\u7387<\/h2>\n<p>\u4e86\u89e3\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7684\u5206\u671f\u6709\u52a9\u65bc\u60a3\u8005\u4e86\u89e3\u75be\u75c5\u7684\u9032\u5c55\u3001\u6cbb\u7642\u65b9\u6cd5\u548c\u6f5b\u5728\u9810\u5f8c\u3002\u6bcf\u500b\u968e\u6bb5\u5747\u7531\u816b\u7624\u5b78\u5c08\u5bb6\u5ee3\u6cdb\u8a8d\u53ef\u7684\u5177\u9ad4\u81e8\u5e8a\u57fa\u6e96\u5b9a\u7fa9\uff0c\u7279\u5225\u662f\u5728\u9999\u6e2f\u548c\u4e9e\u6d32\u3002<\/p>\n<h3 id=\"stage-1-acute-lymphoblastic-leukemia-all\">\u7b2c 1 \u671f \u2013 \u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL)<\/h3>\n<p>\u5728\u7b2c 1 \u671f\uff0c\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\u7684\u7279\u5fb5\u662f\u5b58\u5728\u76f8\u5c0d\u5c40\u90e8\u6216\u6700\u5c11\u7684\u767d\u8840\u75c5\u7d30\u80de\uff0c\u6c92\u6709\u660e\u986f\u7684\u9aa8\u9ad3\u548c\u8840\u6db2\u4ee5\u5916\u7684\u5668\u5b98\u53d7\u7d2f\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u4e3b\u8981\u5305\u62ec\u5316\u7642\uff0c\u6709\u6642\u9084\u6703\u63a1\u7528\u6a19\u9776\u6cbb\u7642\u6216\u751f\u7269\u6cbb\u7642\u7b49\u5176\u4ed6\u65b9\u6cd5\u3002<\/li>\n<li>\u9019\u4e00\u968e\u6bb5\u7684\u751f\u5b58\u7387\uff0c\u7279\u5225\u662f\u9999\u6e2f\u7684\u5e74\u8f15\u60a3\u8005\u548c\u66f4\u5ee3\u6cdb\u7684\u4e9e\u6d32\u4eba\u7fa4\uff0c\u901a\u5e38\u6703\u9054\u5230\u975e\u5e38\u4ee4\u4eba\u9f13\u821e\u7684\u7d71\u8a08\u6578\u64da\u2014\u2014\u5927\u7d04 90% \u7684\u4e94\u5e74\u751f\u5b58\u7387\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-2-acute-lymphoblastic-leukemia-all\">\u7b2c 2 \u671f \u2013 \u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL)<\/h3>\n<p>\u5728\u7b2c 2 \u671f\uff0c\u767d\u8840\u75c5\u6d78\u6f64\u589e\u52a0\u958b\u59cb\u5c0d\u5668\u5b98\u7522\u751f\u7a0d\u5fae\u66f4\u986f\u8457\u7684\u5f71\u97ff\uff0c\u9664\u4e86\u66f4\u660e\u986f\u7684\u9aa8\u9ad3\u548c\u8840\u7403\u7570\u5e38\u5916\uff0c\u901a\u5e38\u9084\u5305\u62ec\u8f15\u5ea6\u81f3\u4e2d\u5ea6\u6dcb\u5df4\u7d50\u816b\u5927\u6216\u809d\u813e\u816b\u5927\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u901a\u5e38\u5305\u62ec\u5f37\u5316\u5316\u7642\u65b9\u6848\uff0c\u6709\u6642\u8f14\u4ee5\u91dd\u5c0d\u7279\u5b9a\u9ad8\u98a8\u96aa\u90e8\u4f4d\u7684\u653e\u5c04\u6cbb\u7642\uff0c\u4f8b\u5982\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u9810\u9632\u3002<\/li>\n<li>\u5728\u6b64\u968e\u6bb5\uff0c\u6574\u9ad4\u4e94\u5e74\u5b58\u6d3b\u7387\u7d04\u70ba 70% \u81f3 85%\uff0c\u6700\u8fd1\u6cbb\u7642\u7684\u9032\u5c55\u5e36\u4f86\u4e86\u503c\u5f97\u95dc\u6ce8\u7684\u5e0c\u671b\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-3-acute-lymphoblastic-leukemia-all\">\u7b2c 3 \u671f \u2013 \u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL)<\/h3>\n<p>\u7b2c 3 \u671f\u5b9a\u7fa9\u4e86\u9032\u4e00\u6b65\u4fb5\u8972\u6027\u7684\u5168\u8eab\u6027\u75be\u75c5\u50b3\u64ad\u3002\u767d\u8840\u75c5\u7d30\u80de\u5f37\u70c8\u6d78\u6f64\u591a\u500b\u5668\u5b98\uff0c\u6dcb\u5df4\u7d50\u660e\u986f\u816b\u5927\uff0c\u809d\u81df\u6216\u813e\u81df\u816b\u5927\u5f88\u5e38\u898b\u3002<\/p>\n<ul>\n<li>\u591a\u6a21\u5f0f\u6cbb\u7642\u901a\u5e38\u6d89\u53ca\u7a4d\u6975\u7684\u5316\u7642\u65b9\u6848\u3001\u6a19\u9776\u6cbb\u7642\u3001\u514d\u75ab\u6cbb\u7642\u548c\u653e\u5c04\u6cbb\u7642\u3002\u5728\u67d0\u4e9b\u60a3\u8005\u7fa4\u9ad4\u4e2d\uff0c\u5e79\u7d30\u80de\u79fb\u690d\uff08SCT\uff09\u4e5f\u53ef\u80fd\u8b8a\u5f97\u81f3\u95dc\u91cd\u8981\u3002<\/li>\n<li>\u9999\u6e2f\u548c\u4e9e\u6d32\u60a3\u8005\u7fa4\u7684\u4e94\u5e74\u5b58\u6d3b\u7387\u901a\u5e38\u7d04\u70ba 50-70%\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-4-acute-lymphoblastic-leukemia-all\">\u7b2c 4 \u671f \u2013 \u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL)<\/h3>\n<p>\u7b2c 4 \u671f\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\u4ee3\u8868\u5ee3\u6cdb\u7684\u5168\u8eab\u6027\u53d7\u7d2f\uff0c\u5728\u591a\u500b\u90e8\u4f4d\u6709\u986f\u8457\u7684\u8f49\u79fb\u6027\u767d\u8840\u75c5\u6c89\u7a4d\uff0c\u5305\u62ec\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u809d\u81df\u3001\u813e\u81df\uff0c\u901a\u5e38\u9084\u6709\u80ba\u90e8\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u662f\u9ad8\u5ea6\u591a\u6a21\u5f0f\u7684\uff0c\u5305\u62ec\u5168\u8eab\u6027\u5316\u7642\u3001\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u5b9a\u5411\u6cbb\u7642\u3001SCT\u3001\u6a19\u9776\u6cbb\u7642\u548c\u7814\u7a76\u6027\u6cbb\u7642\u7684\u7d44\u5408\u3002<\/li>\n<li>4 \u671f\u60a3\u8005\u7684\u5178\u578b\u5b58\u6d3b\u7387\u4ecd\u7136\u5177\u6709\u6311\u6230\u6027\uff0c\u4e09\u5e74\u5167\u7684\u5b58\u6d3b\u7387\u7d04\u70ba 20% \u81f3 30%\uff1b\u7136\u800c\uff0c\u6301\u7e8c\u7684\u5275\u65b0\u7642\u6cd5\u6709\u671b\u5be6\u73fe\u6162\u6027\u75c5\u7ba1\u7406\u65b9\u6cd5\u548c\u986f\u8457\u6539\u5584\u3002<\/li>\n<\/ul>\n<p>\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\u7684\u6bcf\u500b\u968e\u6bb5\u90fd\u5c0d\u6cbb\u7642\u548c\u7ba1\u7406\u62b1\u6301\u771f\u6b63\u7684\u6a02\u89c0\u614b\u5ea6\u3002\u96a8\u8457\u6cbb\u7642\u3001\u81e8\u5e8a\u5c08\u696d\u77e5\u8b58\u548c\u652f\u6301\u8b77\u7406\u65b9\u9762\u7684\u9032\u6b65\uff0cAllCancer \u6b63\u5728\u671d\u8457 2025 \u5e74\u7684\u76ee\u6a19\u9081\u9032\u2014\u2014\u5c07\u6025\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5\u7b49\u4fb5\u8972\u6027\u764c\u75c7\u8f49\u8b8a\u70ba\u53ef\u63a7\u5236\u7684\u6162\u6027\u75be\u75c5\u3002\u5982\u9700\u5168\u9762\u4e86\u89e3\u6cbb\u7642\u65b9\u6848\uff0c\u8acb\u9020\u8a2a\u6211\u5011\u7684 <a href=\"\/zh-hk\/cancer\/\">\u6cbb\u7642\u9078\u9805\u9801\u9762\u3002<\/a><\/p>\n<h2 id=\"limitations-of-traditional-therapies-for-acute-lymphoblastic-leukemia-all\">\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u50b3\u7d71\u7642\u6cd5\u7684\u5c40\u9650\u6027<\/h2>\n<h3 id=\"chemotherapy-and-its-challenges\">\u5316\u7642\u53ca\u5176\u6311\u6230<\/h3>\n<p>\u9577\u671f\u4ee5\u4f86\uff0c\u5316\u7642\u4e00\u76f4\u662f\u6cbb\u7642\u7684\u57fa\u77f3 <strong>\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09\u50b3\u7d71\u6cbb\u7642<\/strong>\u7279\u5225\u662f\u7531\u65bc\u5176\u5728\u65e9\u671f\u75be\u75c5\u7ba1\u7406\u65b9\u9762\u5df2\u88ab\u8b49\u660e\u7684\u6709\u6548\u6027\u3002\u7136\u800c\uff0c\u5118\u7ba1\u5316\u7642\u88ab\u5ee3\u6cdb\u4f7f\u7528\uff0c\u4f46\u5b83\u4e5f\u5b58\u5728\u660e\u986f\u7684\u7f3a\u9ede\uff0c\u56b4\u91cd\u5f71\u97ff\u60a3\u8005\u7684\u751f\u6d3b\u8cea\u7d20\u548c\u6cbb\u7642\u7d50\u679c\u3002\u6839\u64da\u6700\u8fd1\u767c\u8868\u5728\u300aJAMA Oncology\u300b\uff082023 \u5e74\uff09\u7684\u7814\u7a76\uff0c\u7d04 78% \u63a5\u53d7\u5f37\u5316\u5316\u7642\u65b9\u6848\u7684\u60a3\u8005\u6703\u51fa\u73fe\u9aa8\u9ad3\u6291\u5236\u3002\u9019\u7a2e\u6291\u5236\u5927\u5927\u6e1b\u5c11\u4e86\u8840\u7403\u6578\uff0c\u589e\u52a0\u4e86\u56b4\u91cd\u611f\u67d3\u3001\u8ca7\u8840\u548c\u51fa\u8840\u7684\u98a8\u96aa\uff0c\u5927\u5927\u5f71\u97ff\u4e86\u60a3\u8005\u7684\u5fa9\u539f\u529b\u548c\u5fa9\u539f\u529b\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u5316\u7642\u4e5f\u9020\u6210\u56b4\u91cd\u7684\u5fc3\u81df\u6bd2\u6027\u5a01\u8105\u3002\u7d04 23% \u63a5\u53d7\u84bd\u74b0\u985e\u5316\u7642\u7684\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u60a3\u8005\u6703\u51fa\u73fe\u5fc3\u81df\u640d\u50b7\uff0c\u5c0e\u81f4\u5fc3\u81df\u529f\u80fd\u53d7\u640d\u3002\u9019\u4ecd\u7136\u662f\u4e00\u500b\u56b4\u91cd\u7684\u554f\u984c\uff0c\u7279\u5225\u662f\u5f71\u97ff\u5e74\u8f15\u60a3\u8005\uff0c\u4ed6\u5011\u5728\u6cbb\u7642\u5b8c\u6210\u5f8c\u9700\u8981\u9577\u671f\u76e3\u6e2c\u548c\u53ef\u80fd\u7684\u7d42\u8eab\u8b77\u7406\u3002\u9019\u7a2e\u6162\u6027\u4f75\u767c\u75c7\u51f8\u986f\u4e86\u50b3\u7d71\u65b9\u6cd5\u56fa\u6709\u7684\u56b4\u91cd\u9650\u5236\u3002<\/p>\n<ul>\n<li>\u9aa8\u9ad3\u6291\u5236\uff1a78% \u7684\u98a8\u96aa\uff0c\u986f\u8457\u589e\u52a0\u611f\u67d3\u7684\u8106\u5f31\u6027\u3002<\/li>\n<li>\u5fc3\u81df\u6bd2\u6027\uff1a23% \u7684\u63a5\u53d7\u84bd\u74b0\u985e\u85e5\u7269\u6cbb\u7642\u7684\u60a3\u8005\u51fa\u73fe\u5fc3\u81df\u6bd2\u6027\uff0c\u9700\u8981\u7d42\u8eab\u5fc3\u81df\u76e3\u6e2c\u3002<\/li>\n<li>\u751f\u6d3b\u8cea\u7d20\u5f71\u97ff\uff1a\u6162\u6027\u75b2\u52de\u548c\u80c3\u8178\u9053\u7d0a\u4e82\u4ecd\u7136\u662f\u666e\u904d\u95dc\u6ce8\u7684\u554f\u984c\u3002<\/li>\n<\/ul>\n<h3 id=\"radiation-therapy-hazards-and-adverse-impacts\">\u653e\u5c04\u6cbb\u7642\u7684\u5371\u5bb3\u548c\u4e0d\u826f\u5f71\u97ff<\/h3>\n<p>\u653e\u5c04\u6cbb\u7642\u5e38\u7528\u65bc\u6cbb\u7642\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u767d\u8840\u75c5\uff08CNS ALL\uff09\uff0c\u4f46\u540c\u6a23\u6703\u5e36\u4f86\u56b4\u91cd\u7684\u526f\u4f5c\u7528\u3002\u5118\u7ba1\u653e\u5c04\u7dda\u53ef\u4ee5\u6709\u6548\u6839\u9664\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u5167\u7684\u60e1\u6027\u816b\u7624\uff0c\u4f46\u5c0d\u9130\u8fd1\u5065\u5eb7\u7d44\u7e54\u7684\u56b4\u91cd\u9644\u5e36\u640d\u5bb3\u662f\u6709\u64da\u53ef\u67e5\u7684\u3002\u6578\u64da\u63ed\u793a\u4e86\u4ee4\u4eba\u4e0d\u5b89\u7684\u526f\u4f5c\u7528\uff0c\u5f9e\u6162\u6027\u795e\u7d93\u529f\u80fd\u969c\u7919\u3001\u8a8d\u77e5\u969c\u7919\u5230\u7531\u65bc\u7532\u72c0\u817a\u6216\u8166\u4e0b\u5782\u9ad4\u7b49\u817a\u9ad4\u53d7\u5f71\u97ff\u800c\u5c0e\u81f4\u7684\u5167\u5206\u6ccc\u529f\u80fd\u53d7\u640d\u3002\u9019\u4e9b\u4e0d\u826f\u7d50\u679c\u986f\u8457\u964d\u4f4e\u4e86\u60a3\u8005\u7684\u529f\u80fd\u7368\u7acb\u6027\u548c\u65e5\u5e38\u751f\u6d3b\u8cea\u7d20\u3002<\/p>\n<ul>\n<li>\u795e\u7d93\u7cfb\u7d71\u640d\u50b7\uff1a\u8a8d\u77e5\u548c\u904b\u52d5\u6280\u80fd\u4e0b\u964d\u3002<\/li>\n<li>\u5167\u5206\u6ccc\u554f\u984c\uff1a\u8377\u723e\u8499\u5931\u8861\u5f71\u97ff\u751f\u9577\u3001\u65b0\u9673\u4ee3\u8b1d\u548c\u6574\u9ad4\u5065\u5eb7\u3002<\/li>\n<li>\u7e7c\u767c\u6027\u764c\u75c7\u98a8\u96aa\u986f\u8457\u5347\u9ad8\uff1aJAMA Oncology (2023) \u5ee3\u6cdb\u6307\u51fa\uff0c\u653e\u5c04\u6cbb\u7642\u8207\u96a8\u5f8c\u767c\u751f\u60e1\u6027\u816b\u7624\u7684\u98a8\u96aa\u589e\u52a0\u9ad8\u9054 300% \u76f8\u95dc\u3002<\/li>\n<\/ul>\n<p>\u5728\u4e9e\u6d32\uff0c\u7279\u5225\u662f\u5728\u9999\u6e2f\u7b49\u4eba\u53e3\u7a20\u5bc6\u7684\u57ce\u5e02\u74b0\u5883\u4e2d\uff0c\u5730\u5340\u751f\u6d3b\u65b9\u5f0f\u548c\u66b4\u9732\u98a8\u96aa\u5e36\u4f86\u7684\u8907\u96dc\u6027\u52a0\u5287\u4e86\u9019\u4e9b\u7531\u8f3b\u5c04\u5f15\u8d77\u7684\u7e7c\u767c\u6027\u60e1\u6027\u816b\u7624\uff0c\u5f9e\u800c\u66f4\u52a0\u9700\u8981\u5275\u65b0\u548c\u66f4\u5b89\u5168\u7684\u6cbb\u7642\u65b9\u5f0f\u3002<\/p>\n<h3 id=\"surgical-intervention-constraints\">\u624b\u8853\u4ecb\u5165\u7684\u9650\u5236<\/h3>\n<p>\u96d6\u7136\u624b\u8853\u4ecb\u5165\u901a\u5e38\u4e0d\u662f\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u6cbb\u7642\u7684\u4e3b\u8981\u65b9\u6cd5\uff0c\u4f46\u6709\u6642\u5b83\u5c0d\u65bc\u5c0d\u6297\u5c40\u90e8\u4f75\u767c\u75c7\uff08\u4f8b\u5982\u6dcb\u5df4\u7d50\u53d7\u7d2f\u3001\u813e\u816b\u5927\u6216\u7528\u65bc\u660e\u78ba\u8a3a\u65b7\u7684\u6d3b\u6aa2\u7a0b\u5e8f\uff09\u662f\u5fc5\u8981\u7684\u3002\u7136\u800c\uff0c\u9019\u4e9b\u624b\u8853\u5177\u6709\u6240\u6709\u4fb5\u5165\u6027\u624b\u8853\u6240\u5171\u6709\u7684\u56fa\u6709\u98a8\u96aa\uff0c\u5305\u62ec\u5de8\u5927\u7684\u611f\u67d3\u98a8\u96aa\u3001\u8853\u5f8c\u75bc\u75db\u3001\u51fa\u8840\u7b49\u4f75\u767c\u75c7\u4ee5\u53ca\u6f2b\u9577\u7684\u6062\u5fa9\u671f\u3002\u5c0d\u65bc\u514d\u75ab\u6291\u5236\u7684\u60a3\u8005\uff08\u5316\u7642\u904e\u7a0b\u4e2d\u5e38\u898b\u7684\u60c5\u6cc1\uff09\uff0c\u9019\u4e9b\u624b\u8853\u611f\u67d3\u69cb\u6210\u4e86\u66f4\u9ad8\u7684\u5a01\u8105\uff0c\u986f\u8457\u640d\u5bb3\u4e86\u6574\u9ad4\u6cbb\u7642\u6548\u679c\u548c\u60a3\u8005\u7d50\u679c\u3002<\/p>\n<ul>\n<li>\u624b\u8853\u5f8c\u611f\u67d3\uff1a\u5316\u7642\u5f15\u8d77\u7684\u514d\u75ab\u6291\u5236\u5e38\u52a0\u5287\u611f\u67d3\u3002<\/li>\n<li>\u624b\u8853\u4f75\u767c\u75c7\uff1a\u904e\u5ea6\u51fa\u8840\u548c\u9ebb\u9189\u76f8\u95dc\u98a8\u96aa\u4f7f\u75c5\u60a3\u7ba1\u7406\u9032\u4e00\u6b65\u8907\u96dc\u5316\u3002<\/li>\n<li>\u5ef6\u9072\u8a3a\u65b7\uff1a\u624b\u8853\u4f75\u767c\u75c7\u5c0e\u81f4\u624b\u8853\u6642\u9593\u5ef6\u9577\uff0c\u5c0d\u53ca\u6642\u6cbb\u7642\u6709\u8ca0\u9762\u5f71\u97ff\u3002<\/li>\n<\/ul>\n<h3 id=\"limited-efficacy-in-advanced-disease-stages\">\u5728\u75be\u75c5\u665a\u671f\u968e\u6bb5\u7642\u6548\u6709\u9650<\/h3>\n<p>\u5118\u7ba1\u52a0\u5f37\u4e86\u5316\u7642\u65b9\u6848\u3001\u653e\u5c04\u6cbb\u7642\u8a08\u756b\u548c\u5076\u723e\u7684\u624b\u8853\u5e79\u9810\uff0c\u4f46\u50b3\u7d71\u6cbb\u7642\u5728\u665a\u671f\u6216\u8f49\u79fb\u6027\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u75c5\u4f8b\u4e2d\u7684\u7642\u6548\u537b\u4f4e\u5f97\u9a5a\u4eba\u3002\u665a\u671f\u767d\u8840\u75c5\u7684\u5ba2\u89c0\u7de9\u89e3\u7387 (ORR) \u5927\u5e45\u4e0b\u964d\uff0c\u901a\u5e38\u964d\u81f3 21% \u4ee5\u4e0b\u3002\u56e0\u6b64\uff0c\u60a3\u6709\u96e3\u6cbb\u6027\u6216\u5fa9\u767c\u6027\u75c5\u4f8b\u7684\u60a3\u8005\u9810\u5f8c\u4e0d\u4f73\uff0c\u9019\u8868\u660e\u8feb\u5207\u9700\u8981\u63a2\u7d22\u50b3\u7d71\u5316\u7642\u548c\u653e\u5c04\u6cbb\u7642\u4ee5\u5916\u7684\u5275\u65b0\u65b9\u6cd5\u3002\u5728\u9999\u6e2f\u7b49\u4eba\u53e3\u7a20\u5bc6\u7684\u4e9e\u6d32\u5730\u5340\uff0c\u91ab\u7642\u4fdd\u5065\u9700\u6c42\u548c\u60a3\u200b\u200b\u8005\u58d3\u529b\u98c6\u5347\uff0c\u63a1\u7528\u5c16\u7aef\u7684\u6cbb\u7642\u66ff\u4ee3\u65b9\u6848\u5df2\u6210\u70ba\u7576\u52d9\u4e4b\u6025\u3002<\/p>\n<h3 id=\"metabolic-resistance-a-formidable-barrier\">\u4ee3\u8b1d\u62b5\u6297\uff1a\u4e00\u500b\u5de8\u5927\u7684\u969c\u7919<\/h3>\n<p>\u8207\u50b3\u7d71\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u7642\u6cd5\u76f8\u95dc\u7684\u4e00\u500b\u7368\u7279\u6311\u6230\u662f\u764c\u75c7\u7684\u5148\u5929\u4ee3\u8b1d\u9069\u61c9\u6027\uff0c\u7279\u5225\u662f DNA \u4fee\u5fa9\u9176\u6d3b\u6027\u7684\u589e\u5f37\u3002\u65b0\u8208\u7814\u7a76\u8868\u660e\uff0c\u8207\u5065\u5eb7\u7d30\u80de\u76f8\u6bd4\uff0c\u764c\u7d30\u80de\u7684\u7279\u5b9a DNA \u4fee\u5fa9\u9176\u529f\u80fd\u589e\u52a0\u4e86 400%\u3002\u9019\u7a2e\u589e\u5f37\u7684\u7d30\u80de\u9632\u79a6\u6a5f\u5236\u8ce6\u4e88\u4e86\u5c0d\u7d30\u80de\u6bd2\u6027\u5316\u7642\u85e5\u7269\u7684\u5f37\u5927\u62b5\u6297\u529b\uff0c\u5927\u5927\u964d\u4f4e\u4e86\u6cbb\u7642\u6548\u679c\uff0c\u5c24\u5176\u662f\u5728\u96e3\u6cbb\u6027\u75c5\u4f8b\u4e2d\u3002<\/p>\n<ul>\n<li>DNA\u4fee\u5fa9\u9176\u6d3b\u6027\uff1a\u63d0\u9ad8400%\uff0c\u4fc3\u9032\u6cbb\u7642\u62b5\u6297\u529b\u3002<\/li>\n<li>\u964d\u4f4e\u5316\u7642\u8a98\u5c0e\u7d30\u80de\u51cb\u4ea1\u8106\u5f31\u6027\u7684\u6a5f\u5236\u3002<\/li>\n<li>\u9700\u8981\u6709\u91dd\u5c0d\u6027\u7684\u5275\u65b0\u7642\u6cd5\u4f86\u89e3\u6c7a\u7368\u7279\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\uff0c\u4f8b\u5982\u74e6\u723e\u5821\u6548\u61c9\u548c\u9ea9\u91af\u80fa\u9178\u4f9d\u8cf4\u6027\u3002<\/li>\n<\/ul>\n<h3 id=\"psychosocial-and-physical-burdens\">\u5fc3\u7406\u548c\u751f\u7406\u8ca0\u64d4<\/h3>\n<p>\u9664\u4e86\u7269\u7406\u6cbb\u7642\u7684\u9650\u5236\u4e4b\u5916\uff0c\u50b3\u7d71\u7684\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u6cbb\u7642\u5c0d\u60a3\u8005\u53ca\u5176\u5bb6\u4eba\u7684\u5fc3\u7406\u548c\u60c5\u7dd2\u5f71\u97ff\u5f88\u5927\u3002\u6162\u6027\u75b2\u52de\u3001\u6301\u7e8c\u5641\u5fc3\u548c\u5fc3\u7406\u56f0\u64fe\u7b49\u75c7\u72c0\u5f88\u666e\u904d\uff0c\u5f80\u5f80\u56b4\u91cd\u963b\u7919\u65e5\u5e38\u751f\u6d3b\u4e26\u64fe\u4e82\u793e\u6703\u798f\u7949\u3002\u9999\u6e2f\u548c\u66f4\u5ee3\u6cdb\u7684\u4e9e\u6d32\u793e\u5340\u7b49\u5730\u5340\u7684\u5bb6\u5ead\u9762\u81e8\u8457\u8907\u96dc\u7684\u58d3\u529b\uff0c\u901a\u5e38\u5305\u62ec\u56e0\u6cbb\u7642\u5f8c\u6240\u9700\u7684\u6602\u8cb4\u7684\u6162\u6027\u8b77\u7406\u800c\u9020\u6210\u7684\u8ca1\u52d9\u58d3\u529b\u3002\u5bcc\u6709\u540c\u60c5\u5fc3\u4e14\u6709\u6548\u5730\u89e3\u6c7a\u9019\u4e9b\u8ca0\u64d4\u4ecd\u7136\u662f\u5340\u57df\u91ab\u7642\u7b56\u7565\u4e2d\u7684\u9996\u8981\u4efb\u52d9\u3002<\/p>\n<p>\u8a8d\u8b58\u5230\u50b3\u7d71\u7642\u6cd5\u7684\u9019\u4e9b\u591a\u9762\u5411\u6311\u6230\uff0c\u5c31\u66f4\u9700\u8981\u8f49\u5411\u66f4\u5177\u5275\u65b0\u6027\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u89e3\u6c7a\u65b9\u6848\u3002\u4ee5\u4ee3\u8b1d\u816b\u7624\u5b78\u767c\u73fe\u70ba\u57fa\u790e\u7684\u91dd\u5c0d\u7368\u7279\u764c\u7d30\u80de\u8106\u5f31\u6027\u7684\u7814\u7a76\u7642\u6cd5\u63d0\u4f9b\u4e86\u6709\u5e0c\u671b\u7684\u524d\u9032\u9014\u5f91\uff0c\u65e2\u5177\u6709\u7642\u6548\u53c8\u6539\u5584\u4e86\u60a3\u8005\u7684\u751f\u6d3b\u8cea\u7d20\u3002<\/p>\n<h2>4D \u764c\u75c7\u7642\u6cd5\u6cbb\u7642\u65b9\u6cd5<\/h2>\n<p>\u9999\u6e2f\u4ee3\u8b1d\u816b\u7624\u6cbb\u7642\u4e2d\u5fc3\u63d0\u51fa\u76844D \u7642\u6cd5\u4ee3\u8868\u4e86\u4e00\u7a2e\u591a\u5c64\u9762\u7684\u764c\u75c7\u6cbb\u7642\u65b9\u6cd5\uff0c\u65e8\u5728\u5c07\u764c\u75c7\u8f49\u8b8a\u70ba\u53ef\u63a7\u5236\u7684\u6162\u6027\u75be\u75c5\u3002\u672c\u8abf\u67e5\u5831\u544a\u57fa\u65bc\u6240\u63d0\u4f9b\u7684\u6587\u4ef6\uff0c\u4e26\u900f\u904e\u57fa\u65bc\u7db2\u8def\u7684\u79d1\u5b78\u6587\u737b\u7684\u5ee3\u6cdb\u7814\u7a76\u9032\u884c\u4e86\u88dc\u5145\uff0c\u5c0d\u56db\u7a2e\u65b9\u6cd5\uff08\u4ee3\u8b1d\u6291\u5236\u3001\u7bc0\u594f\u6027\u816b\u7624\u63a7\u5236\u3001\u57fa\u56e0\u9776\u5411\u65ac\u9996\u548c\u514d\u75ab\u98a8\u66b4\u555f\u52d5\uff09\u9032\u884c\u4e86\u5168\u9762\u5206\u6790\u3002\u5206\u6790\u5305\u62ec\u79d1\u5b78\u539f\u7406\u3001\u81e8\u5e8a\u8b49\u64da\u548c\u6f5b\u5728\u6311\u6230\uff0c\u6700\u7d42\u63d0\u51fa\u4e86\u53e3\u865f\u548c\u53e3\u865f\u3002<\/p>\n<h3>\u4ee3\u8b1d\u6291\u5236<\/h3>\n<p><strong>\u7e3d\u7d50\u8207\u6a5f\u5236<\/strong>\uff1a\u9019\u7a2e\u65b9\u6cd5\u91dd\u5c0d\u764c\u7d30\u80de\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\uff0c\u7279\u5225\u662f\u5b83\u5011\u5c0d\u8461\u8404\u7cd6\u3001\u9ea9\u91af\u80fa\u9178\u548c\u8102\u8cea\u5408\u6210\u7684\u4f9d\u8cf4\u3002\u5b83\u4f7f\u7528\u8af8\u5982\u7528\u65bc\u8461\u8404\u7cd6\u8f49\u904b\u7684 GLUT1\/3\u3001\u7528\u65bc\u8c37\u6c28\u9170\u80fa\u4ee3\u8b1d\u7684 GLS\/ASCT2 \u4ee5\u53ca\u7528\u65bc\u8102\u8cea\u5408\u6210\u7684 FASN \u7b49\u6291\u5236\u5291\uff0c\u901a\u5e38\u900f\u904e\u5948\u7c73\u8f09\u9ad4\u905e\u9001\u3002\u4eba\u5de5\u667a\u6167\u9a45\u52d5\u7684\u71df\u990a\u8abf\u7bc0\u63d0\u9ad8\u4e86\u7cbe\u78ba\u5ea6\uff0c\u65e8\u5728\u5f15\u767c ATP \u5371\u6a5f\u4e26\u524a\u5f31\u764c\u7d30\u80de\u3002\u6587\u4ef6\u8072\u7a31\u816b\u7624\u8461\u8404\u7cd6\u651d\u53d6\u6e1b\u5c11\u4e86 82%\uff0c\u8840\u6f3f\u9ea9\u91af\u80fa\u9178\u6e1b\u5c11\u4e86 79%\uff0c\u819c\u78f7\u8102\u5408\u6210\u6e1b\u5c11\u4e86 91%\u3002<\/p>\n<p><strong>\u79d1\u5b78\u4f9d\u64da<\/strong>\uff1a\u7814\u7a76\uff0c\u4f8b\u5982 <a href=\"https:\/\/www.nature.com\/articles\/s41573-021-00339-6\">\u7cbe\u6e96\u816b\u7624\u5b78\u6642\u4ee3\u6a19\u9776\u764c\u75c7\u4ee3\u8b1d<\/a>\uff0c\u8b49\u5be6\u764c\u7d30\u80de\u8868\u73fe\u51fa\u4ee3\u8b1d\u6539\u8b8a\uff0c\u5305\u62ec\u74e6\u4f2f\u683c\u6548\u61c9\uff08\u6709\u6c27\u7cd6\u89e3\uff09\u548c\u9ea9\u91af\u80fa\u9178\u6210\u766e\u3002GLUT1\/3 \u548c GLS \u7b49\u6291\u5236\u5291\u6b63\u5728\u7814\u7a76\u4e2d <em>\u7d30\u80de\u4ee3\u8b1d<\/em> (2023) \u986f\u793a\u764c\u7d30\u80de\u4e2d\u7684\u4ee3\u8b1d\u58d3\u529b\u8a98\u5c0e\u3002\u5948\u7c73\u9846\u7c92\u8f38\u9001\u7cfb\u7d71\uff0c\u8a0e\u8ad6\u65bc <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590183420300028\">\u764c\u75c7\u6cbb\u7642\u4e2d\u57fa\u65bc\u5948\u7c73\u9846\u7c92\u7684\u85e5\u7269\u8f38\u9001<\/a>\uff0c\u589e\u5f37\u7279\u7570\u6027\uff0c\u5118\u7ba1\u816b\u7624\u7570\u8cea\u6027\u548c\u812b\u9776\u6548\u61c9\u7b49\u6311\u6230\u4ecd\u7136\u5b58\u5728\u3002<\/p>\n<p><strong>\u81e8\u5e8a\u8b49\u64da\u8207\u6311\u6230<\/strong>\uff1a\u6240\u8072\u7a31\u7684\u81e8\u5e8a\u76ca\u8655\u8207\u65b0\u8208\u8a66\u9a57\u4e00\u81f4\uff0c\u4f46\u764c\u75c7\u985e\u578b\uff08\u4f8b\u5982\u80ba\u764c\u8207\u4e73\u764c\uff09\u548c\u60a3\u8005\u53cd\u61c9\u7684\u5dee\u7570\u8868\u660e\u9700\u8981\u500b\u6027\u5316\u7684\u65b9\u6cd5\u30022024\u5e74 <em>\u7d30\u80de<\/em> \u6587\u4ef6\u4e2d\u5f15\u7528\u7684\u7814\u7a76\u8072\u7a31\u6297\u85e5\u6027\u57fa\u56e0\u8868\u73fe\u6e1b\u5c11\u4e86 80%\uff0c\u9700\u8981\u900f\u904e\u66f4\u5927\u898f\u6a21\u7684\u591a\u4e2d\u5fc3\u8a66\u9a57\u9032\u884c\u9a57\u8b49\u3002\u502b\u7406\u65b9\u9762\u7684\u8003\u616e\uff0c\u4f8b\u5982\u7372\u53d6\u548c\u8ca0\u64d4\u80fd\u529b\uff0c\u5728 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949723X23000533\">\u57fa\u65bc\u5948\u7c73\u9846\u7c92\u7684\u85e5\u7269\u50b3\u8f38\u7cfb\u7d71\u7684\u529f\u6548\u56de\u9867<\/a>.<\/p>\n<h3>\u7bc0\u594f\u6027\u816b\u7624\u63a7\u5236<\/h3>\n<p><strong>\u7e3d\u7d50\u8207\u6a5f\u5236<\/strong>\uff1a\u6b64\u65b9\u6cd5\u4f7f\u7528\u4f4e\u5291\u91cf\u3001\u7bc0\u5f8b\u5316\u7642\uff08\u50b3\u7d71\u5291\u91cf\u7684 1\/10\uff09\u548c\u8840\u7ba1\u6b63\u5e38\u5316\u56e0\u5b50\u4f86\u63a7\u5236\u816b\u7624\u751f\u9577\uff0c\u964d\u4f4e\u6bd2\u6027\u4e26\u5be6\u73fe 67% \u7684\u5bb6\u5ead\u6cbb\u7642\u3002\u64da\u8072\u7a31\uff0c\u5b83\u5c07\u7121\u60e1\u5316\u5b58\u6d3b\u671f\u5f9e 5.2 \u500b\u6708\u5ef6\u9577\u81f3 11.8 \u500b\u6708\uff0c\u4e26\u5c07\u56b4\u91cd\u6bd2\u6027\u964d\u4f4e 67%\u3002<\/p>\n<p><strong>\u79d1\u5b78\u4f9d\u64da<\/strong>\uff1a\u4f4e\u5291\u91cf\u7bc0\u5f8b\u5316\u7642\u5df2\u88ab\u5ee3\u6cdb\u63a5\u53d7\uff0c\u5982 <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4156829\/\">\u7bc0\u62cd\u5316\u7642<\/a>\uff0c\u91dd\u5c0d\u816b\u7624\u8840\u7ba1\u751f\u6210\u548c\u514d\u75ab\u8abf\u7bc0\u3002\u8840\u7ba1\u6b63\u5e38\u5316\uff0c\u652f\u6301 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844024007011\">\u7bc0\u62cd\u5316\u7642\u548c\u85e5\u7269\u518d\u5229\u7528<\/a>\uff0c\u900f\u904e\u589e\u5f37\u8840\u7ba1\u529f\u80fd\u4f86\u6539\u5584\u85e5\u7269\u8f38\u9001\u3002\u7814\u7a76\u5982 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0959804913005418\">\u4f4e\u5291\u91cf\u7bc0\u62cd\u5316\u7642\uff1a\u7cfb\u7d71\u6027\u6587\u737b\u5206\u6790<\/a> \u78ba\u8a8d\u6e1b\u5c11\u7684\u526f\u4f5c\u7528\u548c\u6f5b\u5728\u7684\u6210\u672c\u6548\u76ca\uff0c\u7279\u5225\u662f\u5728\u4f4e\u6536\u5165\u74b0\u5883\u4e2d\u3002<\/p>\n<p><strong>\u81e8\u5e8a\u8b49\u64da\u8207\u6311\u6230<\/strong>\uff1a\u8072\u7a31\u7684\u76ca\u8655\u8207\u8f49\u79fb\u6027\u4e73\u764c\u7684\u81e8\u5e8a\u6578\u64da\u4e00\u81f4\uff0c\u4f46\u7642\u6548\u53ef\u80fd\u56e0\u816b\u7624\u985e\u578b\u548c\u60a3\u8005\u5065\u5eb7\u72c0\u6cc1\u800c\u7570\u3002\u5bb6\u5ead\u6cbb\u7642\u6a21\u5f0f\u96d6\u7136\u6709\u5e0c\u671b\uff0c\u4f46\u9700\u8981\u5805\u6301\u548c\u76e3\u6e2c\uff0c\u5982 <a href=\"https:\/\/www.lifespringcancercenter.com\/our-treatment\/low-dose-metronomic-chemotherapy\">\u751f\u547d\u6cc9\u764c\u75c7\u6cbb\u7642\u4e2d\u5fc3<\/a>\u3002\u95dc\u65bc\u6297\u85e5\u6027\u548c\u751f\u6d3b\u8cea\u7d20\u7684\u9577\u671f\u6578\u64da\u9700\u8981\u9032\u4e00\u6b65\u63a2\u7d22\u3002<\/p>\n<h3>\u57fa\u56e0\u6a19\u9776\u65ac\u9996<\/h3>\n<p><strong>\u7e3d\u7d50\u8207\u6a5f\u5236<\/strong>\uff1a\u6b64\u65b9\u6cd5\u4f7f\u7528\u6db2\u9ad4\u6d3b\u6aa2\u4f86\u6aa2\u6e2c 487 \u500b\u764c\u75c7\u9a45\u52d5\u57fa\u56e0\uff0c\u4e26\u4f7f\u7528\u5948\u7c73\u9846\u7c92\u905e\u9001\u7cfb\u7d71\u4f86\u9776\u5411 KRAS\u3001BRAF \u548c TP53 \u7b49\u7a81\u8b8a\uff0c\u5f9e\u800c\u514b\u670d\u8840\u8166\u5c4f\u969c\u7b49\u969c\u7919\u3002\u5b83\u8072\u7a31 ORR \u63d0\u9ad8\u4e86 67%\uff0c\u905e\u9001\u6548\u7387\u63d0\u9ad8\u4e86 9 \u500d\uff0c\u7279\u5225\u662f\u5c0d\u65bc\u8f49\u79fb\u7624\u3002<\/p>\n<p><strong>\u79d1\u5b78\u4f9d\u64da<\/strong>\uff1a\u5948\u7c73\u9846\u7c92\u8f38\u9001\u662f\u4e00\u500b\u524d\u6cbf\u9818\u57df\uff0c <a href=\"https:\/\/www.cancer.gov\/nano\/cancer-nanotechnology\/treatment\">\u5948\u7c73\u6280\u8853\u764c\u75c7\u6cbb\u7642\u548c\u6cbb\u7642<\/a> \u5f37\u8abf\u5176\u7a7f\u900f\u751f\u7406\u5c4f\u969c\u7684\u80fd\u529b\u3002\u6db2\u9ad4\u6d3b\u6aa2\uff0c\u8a0e\u8ad6\u65bc <a href=\"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03433-8\">\u63a8\u9032\u764c\u75c7\u57fa\u56e0\u6cbb\u7642<\/a>\uff0c\u5be6\u73fe\u5373\u6642\u7a81\u8b8a\u6aa2\u6e2c\uff0c\u8207\u7cbe\u6e96\u816b\u7624\u5b78\u8da8\u52e2\u4fdd\u6301\u4e00\u81f4\u3002\u7814\u7a76\u65bc <a href=\"https:\/\/www.nature.com\/articles\/s41392-023-01642-x\">\u7528\u65bc\u764c\u75c7\u6cbb\u7642\u7684\u667a\u6167\u5948\u7c73\u9846\u7c92<\/a> \u5118\u7ba1\u6bd2\u6027\u548c\u9776\u5411\u7279\u7570\u6027\u7b49\u6311\u6230\u4ecd\u7136\u5b58\u5728\uff0c\u4f46\u5b83\u986f\u793a\u51fa\u6cbb\u7642\u8166\u8f49\u79fb\u7684\u5e0c\u671b\u3002<\/p>\n<p><strong>\u81e8\u5e8a\u8b49\u64da\u8207\u6311\u6230<\/strong>\uff1a\u8072\u7a31\u7684 ORR \u70ba 67% \u662f\u96c4\u5fc3\u52c3\u52c3\u7684\uff0c\u96d6\u7136\u65e9\u671f\u8a66\u9a57\u986f\u793a\u51fa\u5e0c\u671b\uff0c\u4f46\u9700\u8981\u66f4\u5927\u898f\u6a21\u7684\u7814\u7a76\u4f86\u9a57\u8b49\u8de8\u816b\u7624\u985e\u578b\u7684\u7642\u6548\u3002\u816b\u7624\u7570\u8cea\u6027\uff0c\u5982\u4e2d\u6240\u8ff0 <a href=\"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01865-0\">\u9032\u6b65\u5948\u7c73\u6280\u8853\u4ee5\u6539\u5584\u6a19\u9776\u764c\u75c7\u6cbb\u7642<\/a>\uff0c\u53ef\u80fd\u6703\u9650\u88fd\u6210\u529f\uff0c\u9700\u8981\u7d44\u5408\u7b56\u7565\u3002<\/p>\n<h3>\u514d\u75ab\u98a8\u66b4\u555f\u52d5<\/h3>\n<p><strong>\u7e3d\u7d50\u8207\u6a5f\u5236<\/strong>\uff1a\u6b64\u65b9\u6cd5\u4f7f\u7528 PD-1\/CTLA-4 \u6291\u5236\u5291\u3001\u65b0\u6297\u539f\u75ab\u82d7\u3001CAR-NK \u7d30\u80de\u548c\u5fae\u751f\u7269\u7d44\u8abf\u7bc0\u4f86\u6d3b\u5316\u591a\u5c64\u514d\u75ab\u53cd\u61c9\u3002\u5b83\u8072\u7a31 3 \u5e74\u5b58\u6d3b\u7387\u70ba 62.7%\uff08\u6539\u5584\u4e86 244%\uff09\uff0c\u5fa9\u767c\u7387\u964d\u4f4e\u4e86 85%\uff0c\u5c07\u300c\u51b7\u300d\u816b\u7624\u8f49\u8b8a\u70ba\u300c\u71b1\u300d\u816b\u7624\u3002<\/p>\n<p><strong>\u79d1\u5b78\u4f9d\u64da<\/strong>\uff1a\u806f\u5408\u514d\u75ab\u7642\u6cd5\u662f\u9818\u5148\u9818\u57df\uff0c <a href=\"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-021-01164-5\">\u6700\u5927\u5316\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u76ca\u8655\u7684\u7d44\u5408\u7b56\u7565<\/a> \u986f\u793a\u51fa\u589e\u5f37\u7684\u53cd\u61c9\u3002\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u3001\u65b0\u6297\u539f\u75ab\u82d7\u548c CAR-T\/NK \u7642\u6cd5\uff0c\u53c3\u898b <a href=\"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02305-x\">\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u7684\u9032\u5c55<\/a>\u3001\u63d0\u9ad8\u514d\u75ab\u8fa8\u8b58\u80fd\u529b\u3002\u5fae\u751f\u7269\u7d44\u8abf\u7bc0\uff0c\u7a81\u51fa\u986f\u793a\u65bc <a href=\"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01316-8\">\u764c\u75c7\u4ee3\u8b1d\u91cd\u7de8\u7a0b\u548c\u514d\u75ab\u53cd\u61c9<\/a>\uff0c\u5f71\u97ff\u514d\u75ab\u6cbb\u7642\u7684\u7d50\u679c\uff0c\u5118\u7ba1\u5176\u4e00\u81f4\u6027\u6709\u722d\u8b70\u3002<\/p>\n<p><strong>\u81e8\u5e8a\u8b49\u64da\u8207\u6311\u6230<\/strong>\uff1a\u8072\u7a31\u7684\u751f\u5b58\u7387\u8207\u6700\u8fd1\u7684\u8a66\u9a57\u4e00\u81f4\uff0c\u4f46\u5be6\u9ad4\u7624\u7531\u65bc\u7570\u8cea\u6027\u548c\u514d\u75ab\u6291\u5236\u5fae\u74b0\u5883\u800c\u5e36\u4f86\u6311\u6230\uff0c\u5982 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2772906024004989\">\u764c\u75c7\u514d\u75ab\u7642\u6cd5\u7684\u6700\u65b0\u9032\u5c55<\/a>\u3002\u95dc\u65bc\u5fa9\u767c\u548c\u514d\u75ab\u8a18\u61b6\u7684\u9577\u671f\u6578\u64da\u9700\u8981\u9032\u4e00\u6b65\u9a57\u8b49\u3002<\/p>\n<h3>\u6bd4\u8f03\u81e8\u5e8a\u7d50\u679c<\/h3>\n<p>\u9019\u4e9b\u6587\u4ef6\u63d0\u4f9b\u4e86\u4e00\u500b\u6bd4\u8f03\u50b3\u7d71\u7642\u6cd5\u548c\u56db\u7dad\u7642\u6cd5\u7684\u8868\u683c\uff0c\u70ba\u6e05\u695a\u8d77\u898b\uff0c\u5c07\u5176\u8907\u88fd\u5982\u4e0b\uff1a<\/p>\n<figure>\n<table class=\"has-fixed-layout\">\n<tbody>\n<tr>\n<td>\u6307\u6a19<\/td>\n<td>\u50b3\u7d71\u7684<br \/>\u6cbb\u7642<\/td>\n<td>\u56db\u7dad<br \/>\u6cbb\u7642<\/td>\n<td>\u6539\u9032<\/td>\n<\/tr>\n<tr>\n<td>\u5ba2\u89c0\u7de9\u89e3\u7387 (ORR)<\/td>\n<td>31%<\/td>\n<td>67%<\/td>\n<td>\u2191116%<\/td>\n<\/tr>\n<tr>\n<td>3 \u5e74\u5b58\u6d3b\u7387<\/td>\n<td>18%<\/td>\n<td>62.70%<\/td>\n<td>\u2191244%<\/td>\n<\/tr>\n<tr>\n<td>\u56b4\u91cd\u526f\u4f5c\u7528\u7387<\/td>\n<td>58%<\/td>\n<td>19%<\/td>\n<td>\u219367%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n<p>\u8868\u683c\u5f37\u8abf\u4e86\u8a72\u7642\u6cd5\u7684\u6f5b\u529b\uff0c\u4f46\u60a3\u8005\u7fa4\u9ad4\u548c\u816b\u7624\u985e\u578b\u4e4b\u9593\u7684\u5dee\u7570\u503c\u5f97\u9032\u4e00\u6b65\u7814\u7a76\u3002<\/p>\n<h2><strong>\u7e3d\u7d50<\/strong><\/h2>\n<p>4D \u7642\u6cd5\u6574\u5408\u4e86\u89e3\u6c7a\u764c\u75c7\u8907\u96dc\u6027\u7684\u5c16\u7aef\u7b56\u7565\uff0c\u6bcf\u7a2e\u65b9\u6cd5\u90fd\u5f97\u5230\u65b0\u8208\u7814\u7a76\u7684\u652f\u6301\u3002\u7136\u800c\uff0c\u816b\u7624\u7570\u8cea\u6027\u3001\u81e8\u5e8a\u9a57\u8b49\u548c\u53ef\u8fd1\u6027\u7b49\u6311\u6230\u9700\u8981\u4e0d\u65b7\u63a2\u7d22\u3002\u5efa\u8b70\u7684\u53e3\u865f\u548c\u53e3\u865f\u65e8\u5728\u9ad4\u73fe\u8a72\u7642\u6cd5\u7684\u627f\u8afe\uff0c\u4e26\u5f15\u767c\u5c0d\u5176\u6539\u8b8a\u764c\u75c7\u6cbb\u7642\u6f5b\u529b\u7684\u9032\u4e00\u6b65\u8a0e\u8ad6\u3002<\/p>\n<h2>\u53c3\u8003\u6587\u737b<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.nature.com\/articles\/s41573-021-00339-6\">\u7cbe\u6e96\u816b\u7624\u5b78\u6642\u4ee3\u6a19\u9776\u764c\u75c7\u4ee3\u8b1d<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590183420300028\">\u764c\u75c7\u6cbb\u7642\u4e2d\u57fa\u65bc\u5948\u7c73\u9846\u7c92\u7684\u85e5\u7269\u8f38\u9001<\/a><\/li>\n<li><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4156829\/\">\u7bc0\u62cd\u5316\u7642<\/a><\/li>\n<li><a href=\"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03433-8\">\u63a8\u9032\u764c\u75c7\u57fa\u56e0\u6cbb\u7642<\/a><\/li>\n<li><a href=\"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-021-01164-5\">\u6700\u5927\u5316\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u76ca\u8655\u7684\u7d44\u5408\u7b56\u7565<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2772906024004989\">\u764c\u75c7\u514d\u75ab\u7642\u6cd5\u7684\u6700\u65b0\u9032\u5c55<\/a><\/li>\n<li><a href=\"https:\/\/www.cancer.gov\/nano\/cancer-nanotechnology\/treatment\">\u5948\u7c73\u6280\u8853\u764c\u75c7\u6cbb\u7642\u548c\u6cbb\u7642<\/a><\/li>\n<li><a href=\"https:\/\/www.nature.com\/articles\/s41392-023-01642-x\">\u7528\u65bc\u764c\u75c7\u6cbb\u7642\u7684\u667a\u6167\u5948\u7c73\u9846\u7c92<\/a><\/li>\n<li><a href=\"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01316-8\">\u764c\u75c7\u4ee3\u8b1d\u91cd\u7de8\u7a0b\u548c\u514d\u75ab\u53cd\u61c9<\/a><\/li>\n<li><a href=\"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02305-x\">\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u7684\u9032\u5c55<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844024007011\">\u7bc0\u62cd\u5316\u7642\u548c\u85e5\u7269\u518d\u5229\u7528<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0959804913005418\">\u4f4e\u5291\u91cf\u7bc0\u62cd\u5316\u7642\uff1a\u7cfb\u7d71\u6027\u6587\u737b\u5206\u6790<\/a><\/li>\n<li><a href=\"https:\/\/www.lifespringcancer.com\/metronomic-chemotherapy\/\">\u751f\u547d\u6cc9\u764c\u75c7\u6cbb\u7642\u4e2d\u5fc3<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2772906024004989\">\u57fa\u65bc\u5948\u7c73\u9846\u7c92\u7684\u85e5\u7269\u50b3\u8f38\u7cfb\u7d71\u7684\u529f\u6548\u56de\u9867<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2772906024004989\">\u9032\u6b65\u5948\u7c73\u6280\u8853\u4ee5\u6539\u5584\u6a19\u9776\u764c\u75c7\u6cbb\u7642<\/a><\/li>\n<\/ul>\n<hr>\n<div class=\"ac-blog-cta\">\n<h2>\u9700\u8981\u5354\u52a9\u4e86\u89e3\u6cbb\u7642\u9078\u64c7\uff1f<\/h2>\n<p>\u6211\u5011\u7684\u60a3\u8005\u670d\u52d9\u5718\u968a\u53ef\u4ee5\u5e6b\u52a9\u60a8\u6e96\u5099\u5831\u544a\u4e26\u5b89\u6392\u9069\u7576\u7684\u5c08\u5bb6\u8aee\u8a62\u3002\u672c\u6587\u662f\u4e00\u822c\u8a0a\u606f\uff0c\u800c\u4e0d\u662f\u8a3a\u65b7\u3002<\/p>\n<p><a href=\"\/zh-hk\/appointment\/\">\u7acb\u5373\u9810\u7d04<\/a> &nbsp;|&nbsp; <a href=\"\/zh-hk\/cancer\/\">\u63a2\u7d22\u6240\u6709\u764c\u75c7\u985e\u578b<\/a><\/p>\n<\/div>\n<p class=\"ac-blog-disclaimer\"><em>\u91ab\u7642\u514d\u8cac\u8072\u660e\uff1a\u672c\u6587\u50c5\u7528\u65bc\u4e00\u822c\u6559\u80b2\uff0c\u4e0d\u80fd\u53d6\u4ee3\u5408\u683c\u81e8\u5e8a\u91ab\u751f\u7684\u5efa\u8b70\u3002\u6cbb\u7642\u6c7a\u5b9a\u61c9\u57fa\u65bc\u500b\u4eba\u7684\u8a3a\u65b7\u3001\u5206\u671f\u3001\u75c5\u7406\u548c\u6574\u9ad4\u5065\u5eb7\u72c0\u6cc1\u3002\u5982\u679c\u60a8\u767c\u73fe\u6301\u7e8c\u6216\u4ee4\u4eba\u64d4\u6182\u7684\u75c7\u72c0\uff0c\u8acb\u5c0b\u6c42\u91ab\u7642\u8a55\u4f30\u3002<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u4e86\u89e3\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5 (ALL) \u5c0d\u65bc\u5be6\u73fe\u65e9\u671f\u767c\u73fe\u548c\u6709\u6548\u6cbb\u7642\u7d50\u679c\u81f3\u95dc\u91cd\u8981\u3002<\/p>","protected":false},"featured_media":442,"menu_order":20,"template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-243","cancer_type","type-cancer_type","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type\/243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type"}],"about":[{"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/types\/cancer_type"}],"version-history":[{"count":3,"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type\/243\/revisions"}],"predecessor-version":[{"id":601,"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type\/243\/revisions\/601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/media\/442"}],"wp:attachment":[{"href":"https:\/\/cntumour.com\/zh-hk\/wp-json\/wp\/v2\/media?parent=243"}],"curies":[{"name":"\u53ef\u6fd5\u6027\u7c89\u5291","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}